These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32738379)

  • 21. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Wang Y; Parker CE; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD000544. PubMed ID: 27158764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis.
    Ko CW; Singh S; Feuerstein JD; Falck-Ytter C; Falck-Ytter Y; Cross RK;
    Gastroenterology; 2019 Feb; 156(3):748-764. PubMed ID: 30576644
    [No Abstract]   [Full Text] [Related]  

  • 25. Inducing and maintaining remission in ulcerative colitis: role of high-dose, extended-release mesalamine.
    Kao J; Kwok K; Das KM
    J Clin Gastroenterol; 2010 Sep; 44(8):531-5. PubMed ID: 20495466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis: A real-life experience.
    Maconi G; Mezzina N; Landi S; Grillo S; Bezzio C; Bosani M; Pastorelli L; Dell'Era A; Chibbar R; Carmagnola S; Molteni P; Cassinotti A; Massari A; Ardizzone S
    United European Gastroenterol J; 2019 Nov; 7(9):1164-1170. PubMed ID: 31700629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Old but Fancy: Curcumin in Ulcerative Colitis-Current Overview.
    Pituch-Zdanowska A; Dembiński Ł; Banaszkiewicz A
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
    Hanauer SB
    Aliment Pharmacol Ther; 2008 Mar; 27 Suppl 1():15-21. PubMed ID: 18307645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MMX mesalamine.
    Baker DE
    Rev Gastroenterol Disord; 2006; 6(3):146-52. PubMed ID: 16957657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
    Moum B
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
    Clemett D; Markham A
    Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rescue therapy with sulfasalazine prior to immunosuppressive or biological agents in ulcerative colitis poorly controlled with mesalazine].
    Martínez González J; Busto Bea V; Mesonero Gismero F; Parejo Carbonell S; Garrido E; López San Román A
    Gastroenterol Hepatol; 2013 Jan; 36(1):7-10. PubMed ID: 23195755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ulcerative Colitis.
    Sonnenberg E; Siegmund B
    Digestion; 2016; 94(4):181-185. PubMed ID: 27931025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
    Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E
    Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics for induction of remission in ulcerative colitis.
    Kaur L; Gordon M; Baines PA; Iheozor-Ejiofor Z; Sinopoulou V; Akobeng AK
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD005573. PubMed ID: 32128795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild-to-Moderate Ulcerative Colitis Guideline.
    Cross R; Ko CW; Singh S
    Gastroenterology; 2019 Feb; 156(3):768. PubMed ID: 30684447
    [No Abstract]   [Full Text] [Related]  

  • 39. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course.
    Schirmer M; Denson L; Vlamakis H; Franzosa EA; Thomas S; Gotman NM; Rufo P; Baker SS; Sauer C; Markowitz J; Pfefferkorn M; Oliva-Hemker M; Rosh J; Otley A; Boyle B; Mack D; Baldassano R; Keljo D; LeLeiko N; Heyman M; Griffiths A; Patel AS; Noe J; Kugathasan S; Walters T; Huttenhower C; Hyams J; Xavier RJ
    Cell Host Microbe; 2018 Oct; 24(4):600-610.e4. PubMed ID: 30308161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical case of a combination of ulcerative colitis and alopecia areata].
    Safina DD; Abdulkhakov RA; Abdulkhakov SR; Odintsova AKh; Cheremina NA
    Eksp Klin Gastroenterol; 2013; (12):92-6. PubMed ID: 24933997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.